Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Wei Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2035-0134; OpenAlex author ID A5100342625. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 2 papers

Papers 3

  1. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Co-author DOI 10.7150/thno.34559↗
  2. MicroRNA-374 targets JAM-2 regulates the growth and metastasis of human pancreatic cancer cells. Co-author PMID 31737197↗
  3. Resveratrol inhibits hyperglycemia-driven ROS-induced invasion and migration of pancreatic cancer cells via suppression of the ERK and p38 MAPK signaling pathw… Last author DOI 10.3892/ijo.2016.3559↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Hua Chang · 1 shared paper, 2019 · strength 0.11
  2. Jing Tao · 1 shared paper, 2019 · strength 0.11
  3. Shi-Jiang Deng · 1 shared paper, 2019 · strength 0.08
  4. Fengyu Xu · 1 shared paper, 2019 · strength 0.08
  5. Ye Zeng · 1 shared paper, 2019 · strength 0.08
  6. Mingliang Liu · 1 shared paper, 2019 · strength 0.08
  7. Gang Zhao · 1 shared paper, 2019 · strength 0.08
  8. Zhu Zeng · 1 shared paper, 2019 · strength 0.08
  9. Yuhang Hu · 1 shared paper, 2019 · strength 0.08
  10. Chunyou Wang · 1 shared paper, 2019 · strength 0.08
  11. Qingyong Ma · 1 shared paper, 2016 · strength 0.08
  12. Lei Cao · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.